• Galapagos to acquire CellPoint and AboundBio to accelerate access to next-generation cell therapies

    Wednesday June 22nd 2022

  • Pathomation announces CE-IVD mark for clinical diagnostic use of vendor neutral PMA.core software

    Tuesday May 31st 2022

  • CureVac partners with myNEO to identify novel antigen targets for mRNA-based cancer vaccine development

    Wednesday May 25th 2022

  • Ziphius Vaccines and Ghent University publish promising data from self-amplifying RNA platform in Molecular Therapy

    Friday May 6th 2022

  • New study led by Memorial Sloan Kettering Cancer Center (NY, US) shows Idylla™ GeneFusion Assay enables more rapid screening of targetable fusions compared to routine methods

    Wednesday May 4th 2022

  • reMYND’s novel Alzheimer program reports excellent brain exposure and safety profile in Phase 1; transitioning into Phase 2a

    Tuesday May 3rd 2022

  • Kantify and I-Stem Use Artificial Intelligence to discover a promising therapy against a rare disease

    Wednesday April 27th 2022

  • Mithra CDMO announces collaboration with MedinCell for the development of injectable products for Malaria and transplant rejection

    Tuesday April 26th 2022

  • Your news here?

  • Some forms of Alzheimer’s disease hit early in life, can we predict when?

    Friday April 22nd 2022

  • Sequana Medical announces the completion of alfapump implantations in POSEIDON, the North American pivotal alfapump study

    Tuesday April 5th 2022

  • Aligos Therapeutics selects drug candidate ALG-097558, a potent ritonavir-free oral protease inhibitor for the treatment and prevention of COVID-19

    Tuesday April 5th 2022

Strategic Partners